Company: LGN
Filing Date: 2025-04-30
Form Type: DRS/A
Source: 0000950123-25-003868
Chunk: 290

Company: Legence Corp.
Filing Date: 2025-04-30
Form: DRS/A
Chunk 290
---
146.7 million DDTL commitment under its term loan agreement. The proceeds were used or designated to fund acquisition-related payments, and quarterly principal payments increased by 0.25% of the amount drawn. The Company paid debt issuance costs of $1.5 million related to issuing term loans on the DDTL commitment and $2.5 million related to amending the DDTL commitment. On February 27, 2023, the Company amended the term loan agreement to transition its benchmark interest from London Interbank Offered Rate (“LIBOR”) to Secured Overnight Financing Rate (“SOFR”) for an additional credit spread adjustment of 0.10%. F-38

Confidential Treatment Requested by Legence Corp.

Pursuant to 17 C.F.R. Section 200.83

Legence Holdings LLC and Subsidiaries

Notes to Consolidated Financial Statements

On July 31, 2023, the Company secured a $155.0 million incremental term loan, and the proceeds were
used to fund acquisition-related payments. The Company paid debt issuance costs of $3.5 million related to this incremental term loan.

On
January 19, 2024, the Company secured a $125.0 million incremental term loan, and the proceeds were used to fund acquisition-related payments. The Company paid debt issuance costs of $0.9 million related to this incremental term loan.

On June 18, 2024, the Company secured a $125.0 million incremental term loan, and the proceeds were used to fund acquisition-related payments.
The Company paid debt issuance costs of $0.2 million related to this incremental term loan.

On November 21, 2024, the Company secured a
$315.0 million incremental term loan, and the proceeds were used for general corporate purposes, including to fund a shareholder distribution, as discussed in “,” and to fund
acquisition-related payments. The Company paid debt issuance costs of $0.4 million related to this incremental term loan.

Advances under the term
loan agreement may be elected to be treated as either SOFR rate loans or base rate loans. SOFR rate loans bear interest at SOFR plus 3.25% to 3.75% based on the Company’s Consolidated First Lien Net Leverage Ratio (the “Net Leverage
Ratio”), (generally defined as the ratio of indebtedness net of cash to consolidated pro forma adjusted EBITDA for the preceding four fiscal quarters), with a